Cargando…
Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
BACKGROUND: Aicardi–Goutières syndrome (AGS) is a genetically determined disorder with a variable phenotype. Since the original description of AGS, advances in gene sequencing techniques have resulted in a significant broadening of the phenotypic spectrum associated with AGS genes, and new clinical...
Autores principales: | Dell’Isola, Giovanni Battista, Dini, Gianluca, Culpepper, Kaleb Logan, Portwood, Katherin Elizabeth, Ferrara, Pietro, Di Cara, Giuseppe, Verrotti, Alberto, Lodolo, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258176/ https://www.ncbi.nlm.nih.gov/pubmed/36650407 http://dx.doi.org/10.1007/s12519-022-00679-2 |
Ejemplares similares
-
Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019) -
MRI Features Predictive of Aicardi-Goutieres Syndrome
por: Millichap, J. Gordon
Publicado: (2015) -
Aicardi–Goutières Syndrome: Brief Case Report
por: Moscote-Salazar, Luis Rafael, et al.
Publicado: (2018) -
3358 Developmental Outcomes of Aicardi Goutieres Syndrome
por: Adang, Laura, et al.
Publicado: (2019) -
Interferon-α and the calcifying microangiopathy in Aicardi–Goutières syndrome
por: Klok, Melanie D, et al.
Publicado: (2015)